Stock Taper

FRAZIER LIFE SCIENCES MANAGEMENT, L.P.

Latest 13F filing data - Q2 2026

Holdings

(Top positions)
STOCKTICKERSHARES HELD VALUE
Ascendis Pharma A/SASND225.16K$60.05M
Krystal Biotech, Inc.KRYS481.31K$178.89M
Immunocore Holdings plcIMCR484.78K$15.39M
Alkermes plcALKS700.65K$36.71M
Tarsus Pharmaceuticals, Inc.TARS728.64K$45.86M
Palvella Therapeutics, Inc.PVLA882.4K$134.85M
Monte Rosa Therapeutics, Inc.GLUE1M$24.2M
Relay Therapeutics, Inc.RLAY1.02M$19M
Kailera Therapeutics, Inc.KLRA1.1M$24.23M
Cytokinetics, IncorporatedCYTK1.16M$98.81M
Disc Medicine, Inc.IRON1.35M$99.09M
ACADIA Pharmaceuticals Inc.ACAD1.44M$36.39M
BridgeBio Pharma, Inc.BBIO1.55M$115.31M
Design Therapeutics, Inc.DSGN1.81M$26.19M
Applied Aerospace & Defense, Inc.AADX1.92M$52.57M
Evolus, Inc.EOLS2.63M$18.26M
Dyne Therapeutics, Inc.DYN3.15M$70.03M
BioCryst Pharmaceuticals, Inc.BCRX4.01M$40.09M
Aclaris Therapeutics, Inc.ACRS4.93M$26.06M
MannKind CorporationMNKD6.6M$28.12M